FDA 483 - Paket Corp - August 06, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Paket Corp, a drug manufacturer and repacker in Chicago, IL, revealed significant deficiencies in their quality control unit and overall adherence to cGMP. The firm lacked numerous essential written procedures for critical operations such as annual product reviews, QA release, master batch records, process validation, OOS investigations, and change management. Additionally, issues were noted with cleaning procedures, documentation of production activities, and the product recall system.
- Office
- Chicago District Office
- Person
ID · 06616500-055a-4d8c-a6f7-8b3c9237e67e